Spontaneous trigeminal allodynia in rats: A model of primary headache

Headache

Volumn 52, Issue 9, 2012, Pages 1336-1349

  Oshinsky, Michael L ^a   Sanghvi, Menka M ^a   Maxwell, Christina R ^a   Gonzalez, Dorian ^a   Spangenberg, Rebecca J ^a   Cooper, Marnie ^a   Silberstein, Stephen D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

allodynia; animal model; chronic daily headache; headache trigger; migraine; primary headache

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DIHYDROERGOTAMINE; GLYCERYL TRINITRATE; KETOROLAC; SUMATRIPTAN; VALPROIC ACID;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EYE PAIN; GENETIC TRAIT; MATING; MIGRAINE; NONHUMAN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHONOPHOBIA; PREDICTIVE VALUE; PRIMARY HEADACHE; PRIORITY JOURNAL; RAT; SECONDARY HEADACHE; SENSORY STIMULATION; SPONTANEOUS TRIGEMINAL ALLODYNIA; TREATMENT DURATION; TRIGEMINAL NERVE;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; HEADACHE; HUMANS; HYPERALGESIA; RATS; RATS, SPRAGUE-DAWLEY; TRIGEMINAL NERVE;

EID: 84867096228     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02247.x     Document Type: Article

References (59)

1. Lipton RB, Newman LC,. Epidemiology, impact, and comorbidities of migraine headaches in the United States. Neurology. 2003; 60 (Suppl. 2): S2-S8.
2. Bergerot A, Holland PR, Akerman S, et al,. Animal models of migraine: Looking at the component parts of a complex disorder. Eur J Neurosci. 2006; 24: 1517-1534.
3. Buzzi MG, Bonamini M, Moskowitz MA,. Neurogenic model of migraine. Cephalalgia. 1995; 15: 277-280.
4. Ghelardini C, Galeotti N, Grazioli I, Uslenghi C,. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J Pain. 2004; 5: 413-419.
5. Greco R, Gasperi V, Sandrini G, et al,. Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat. Cephalalgia. 2010; 30: 296-302.
6. Phebus LA, Johnson KW,. Dural inflammation model of migraine pain. In:, Crawley JN, ed. Chapter 9. Curr Protoc Neurosci. 2001: Chapter 9:Unit 9.1.
7. Shimazawa M, Hara H,. An experimental model of migraine with aura: Cortical hypoperfusion following spreading depression in the awake and freely moving rat. Clin Exp Pharmacol Physiol. 1996; 23: 890-892.
8. Demirpence S, Kurul SH, Kiray M, Tugyan K, Yilmaz O, Köse G,. The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: A randomized, controlled, experimental study. Curr Ther Res Clin Exp. 2009; 70: 129-135.
9. Eikermann-Haerter K, Moskowitz MA,. Animal models of migraine headache and aura. Curr Opin Neurol. 2008; 21: 294-300.
10. Malick A, Burstein R,. Peripheral and central sensitization during migraine. Funct Neurol. 2000; 15 (Suppl. 3): 28-35.
11. Oshinsky ML, Luo J,. Neurochemistry of trigeminal activation in an animal model of migraine. Headache. 2006; 46: S39-S44.
12. Reuter U, Sanchez Del Rio M, Moskowitz MA,. Experimental models of migraine. Funct Neurol. 2000; 15: 9-18.
13. Wieseler J, Ellis A, Sprunger D, et al,. A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats. J Neurosci Methods. 2010; 185: 236-245.
14. Andreou AP, Summ O, Charbit AR, Romero-Reyes M, Goadsby PJ,. Animal models of headache: From bedside to bench and back to bedside. Expert Rev Neurother. 2010; 10: 389-411.
15. Bramanti P, Grugno R, Vitetta A, Marino S, Di Bella P, Nappi G,. Ictal and interictal hypoactivation of the occipital cortex in migraine with aura. A neuroimaging and electrophysiological study. Funct Neurol. 2005; 20: 169-171.
16. De Tommaso M, Guido M, Libro G, et al,. Interictal lack of habituation of mismatch negativity in migraine. Cephalalgia. 2004; 24: 663-668.
17. Sand T, Zhitniy N, Nilsen KB, Helde G, Hagen K, Stovner LJ,. Thermal pain thresholds are decreased in the migraine preattack phase. Eur J Neurol. 2008; 15: 1199-1205.
18. Schoenen J,. Neurophysiological features of the migrainous brain. Neurol Sci. 2006; 27 (Suppl. 2): S77-S81.
19. Borsook D, Hargreaves R,. Brain imaging in migraine research. Headache. 2010; 50: 1523-1527.
20. Ashkenazi A, Mushtaq A, Yang I, Oshinsky ML,. Ictal and interictal phonophobia in migraine-A quantitative controlled study. Cephalalgia. 2009; 29: 1042-1048.
21. Ashkenazi A, Yang I, Mushtaq A, Oshinsky ML,. Is phonophobia associated with cutaneous allodynia in migraine? J Neurol Neurosurg Psychiatry. 2010; 81: 1256-1260.
22. Oshinsky ML, Gomonchareonsiri S,. Episodic dural stimulation in awake rats: A model for recurrent headache. Headache (US). 2007; 47: 1026-1036.
23. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123: 1703-1709.
24. Ramadan NM, Olesen J,. Classification of headache disorders. Semin Neurol. 2006; 26: 157-162.
25. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL,. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53: 55-63.
26. Blaszczyk JW, Tajchert K, LapoLapo I, Sadowski B,. Acoustic startle and open-field behavior in mice bred for magnitude of swim analgesia. Physiol Behav. 2000; 70: 471-476.
27. Berg WK, Balaban MT,. Startle elicitation: Stimulus parameters, recording techniques, and quantification. In: Startle Modification: Implications for Neuroscience, Cognitive Science, and Clinical Science. 1999; 21-50.
28. Levy D, Burstein R, Strassman AM,. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine. Ann Neurol. 2005; 58: 1531-8249.
29. Oshinsky ML,. Insights from experimental studies into allodynia and its treatment. Curr Pain Headache Rep. 2006; 10: 225-230.
30. Levy D, Strassman AM, Burstein R,. A critical view on the role of migraine triggers in the genesis of migraine pain. Headache. 2009; 49: 953-957.
31. Afridi SK, Matharu MS, Lee L, et al,. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005; 128: 932-939.
32. Burstein R, Jakubowski M,. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol (United States). 2005; 493: 9-14.
33. Christiansen I, Daugaard D, Thomsen LL, Olesen J,. Glyceryl trinitrate induced headache in migraineurs-Relation to attack frequency. Eur J Neurol. 2000; 7: 405-411.
34. Bigal ME, Ashina S, Burstein R, et al,. Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology. 2008; 70: 1525-1533.
35. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J,. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999; 19: 660-667.
36. Hershey AD,. Genetics of migraine headache in children. Curr Pain Headache Rep. 2007; 11: 390-395.
37. Gardner KL,. Genetics of migraine: An update. Headache. 2006; 46 (Suppl. 1): S19-S24.
38. Vincent V,. GTN in migraine. Cephalalgia. 1999; 19: 626.
39. Villalõn CM, Olesen J,. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009; 124: 309-323.
40. Edvinsson L, Ho TW,. CGRP receptor antagonism and migraine. Neurother. 2010; 7: 164-175.
41. Maxwell CR, Spangenberg RJ, Hoek JB, Silberstein SD, Oshinsky ML,. Acetate causes alcohol hangover headache in rats. PLoS ONE. 2010; 5: e15963.
42. Yi N, Xu S, George V, Allison DB,. Mapping multiple quantitative trait loci for ordinal traits. Behav Genet. 2004; 34: 3-15.
43. DiPetrillo K, Wang X, Stylianou IM, Paigen B,. Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet (England). 2005; 21: 683-692.
44. Svendsen KB, Jensen TS, Hansen HJ, Bach FW,. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain. 2005; 114: 473-481.
45. Brefel-Courbon C, Payoux P, Thalamas C, et al,. Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study. Mov Disord. 2005; 20: 1557-1563.
46. Vargas A, Vargas A, Hernandez-Paz R, et al,. Sphygmomanometry-evoked allodynia-a simple bedside test indicative of fibromyalgia: A multicenter developmental study. J. Clin Rheumatol. 2006; 12: 272-274.
47. McGeoch PD, Williams LE, Song T, Lee RR, Huang M, Ramachandran VS,. Post-stroke tactile allodynia and its modulation by vestibular stimulation: A MEG case study. Acta Neurol Scand. 2008; 119: 404-409.
48. Ducreux D, Attal N, Parker F, Bouhassira D,. Mechanisms of central neuropathic pain: A combined psychophysical and fMRI study in syringomyelia. Brain. 2006; 129: 963-976.
49. Honkasalo ML, Kaprio J, Winter T, Heikkila K, Sillanpaa M, Kaskenvuo M,. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 1995; 35: 70-78.
50. Russell MB, Olesen J,. Increased familial risk and evidence of genetic factor in migraine. Br Med J. 1995; 311: 541-544.
51. Mulder EJ, Van Baal C, Gaist D, et al,. Genetic and environmental influences on migraine: A twin study across six countries. Twin Res. 2003; 6: 422-431.
52. Freitag FG,. Divalproex in the treatment of migraine. Psychopharmacol Bull. 2003; 37 (Suppl. 2): 98-115.
53. Kroner-Herwig B, Ruhmland M, Zintel W, Siniatchkin M,. Are migraineurs hypersensitive? A test of the stimulus processing disorder hypothesis. Eur J Pain. 2005; 9: 661-671.
54. Duncko R, Cui L, Hille J, Grillon C, Merikangas KR,. Startle reactivity in children at risk for migraine. Clin Neurophysiol. 2008; 119: 2733-2737.
55. Olesen J, Jansen-Olesen I,. Nitric oxide mechanisms in migraine. Pathol Biol. 2000; 48: 648-657.
56. Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J,. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia. 2003; 23: 877-886.
57. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J,. CGRP may play a causative role in migraine. Cephalalgia. 2002; 22: 54-61.
58. Offenhauser N, Zinck T, Hoffmann J, et al,. CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia. 2005; 25: 225-236.
59. Mogil JS,. Animal models of pain: Progress and challenges. Nat Rev Neurosci. 2009; 10: 283-294.